Screening and Treatment of Colon Cancer


March 13th, 2009 - March 13th, 2012
1.00 AMA PRA Category 1 Credit Hours

Description

According to the National Institutes of Health, In the United States, colon cancer is the fourth most common cancer in men and women. When caught early, it is often curable. This program is supported in part by educational grants from Merck and Astellas.


View the NCCN Colon Cancer Guidelines (PDF file, Adobe Acrobat required).

The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 3/13/2012

Objectives

Upon completion of this educational activity, the participant should be able to: 1.) Describe current advances in the selection of treatment strategies for patients with stages II and III colorectal cancer. 2.)Describe the role of integrating biologics to cytotoxics in the treatment of stage IV colorectal cancer. 3.) Review the current screening guidelines for colorectal cancer screening 4.) Review the pathogenesis and genetics of colon carcinogenesis

Webcasts Files

File Link

PDF of Slides

Download

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.